DOI QR코드

DOI QR Code

Behavioral Predictors Associated With COVID-19 Vaccination and Infection Among Men Who Have Sex With Men in Korea

  • Minsoo Jung (Department of Health Science, Dongduk Women's University College of Natural Science)
  • Received : 2023.08.30
  • Accepted : 2023.10.31
  • Published : 2024.01.31

Abstract

Objectives: This study investigated the impact of socioeconomic factors and sexual orientation-related attributes on the rates of coronavirus disease 2019 (COVID-19) vaccination and infection among men who have sex with men (MSM). Methods: A web-based survey, supported by the National Research Foundation of Korea, was conducted among paying members of the leading online portal for the lesbian, gay, bisexual, transgender, or queer and questioning (LGBTQ+) community in Korea. The study participants were MSM living in Korea (n=942). COVID-19 vaccination and infection were considered dependent variables, while sexual orientation-related characteristics and adherence to non-pharmacological intervention (NPI) practices served as primary independent variables. To ensure analytical precision, nested logistic regression analyses were employed. These were further refined by dividing respondents into 4 categories based on sexual orientation and disclosure (or "coming-out") status. Results: Among MSM, no definitive association was found between COVID-19 vaccination status and factors such as socioeconomic or sexual orientation-related attributes (with the latter including human immunodeficiency virus [HIV] status, sexual orientation, and disclosure experience). However, key determinants influencing COVID-19 infection were identified. Notably, people living with HIV (PLWH) exhibited a statistically significant predisposition towards COVID-19 infection. Furthermore, greater adherence to NPI practices among MSM corresponded to a lower likelihood of COVID-19 infection. Conclusions: This study underscores the high susceptibility to COVID-19 among PLWH within the LGBTQ+ community relative to their healthy MSM counterparts. Consequently, it is crucial to advocate for tailored preventive strategies, including robust NPIs, to protect these at-risk groups. Such measures are essential in reducing the disparities that may emerge in a post-COVID-19 environment.

Keywords

Acknowledgement

This work was supported by the National Research Foundation of Korea Grant, funded by the Korean government (NRF-2022R1F1A1062998).

References

  1. Worldometers. COVID-19 coronavirus pandemic [cited 2023 Jun 21]. Available from: https://www.worldometers.info/coronavirus/ 
  2. Hamel L, Kirzinger A, Munana C, Brodie M. KFF covid-19 vaccine monitor: December 2020; 2020 Dec 15 [cited 2023 May 1]. Available from: https://www.kff.org/coronavirus-covid-19/report/kff-covid-19-vaccine-monitor-december-2020/ 
  3. Our World in Data. Coronavirus (COVID-19) vaccinations [cited 2023 May 11]. Available from: https://ourworldindata.org/covid-vaccinations 
  4. BBC News. Covid: vaccines running out in poorer nations, WHO says; 2021 Jun 21 [cited 2023 Jun 21]. Available from: https://www.bbc.com/news/world-57558401 
  5. Wrigley-Field E, Kiang MV, Riley AR, Barbieri M, Chen YH, Duchowny KA, et al. Geographically targeted COVID-19 vaccination is more equitable and averts more deaths than age-based thresholds alone. Sci Adv 2021;7(40):eabj2099. https://doi.org/10.1126/sciadv.abj2099 
  6. Viswanath K, Bekalu M, Dhawan D, Pinnamaneni R, Lang J, McLoud R. Individual and social determinants of COVID-19 vaccine uptake. BMC Public Health 2021;21(1):818. https://doi.org/10.1186/s12889-021-10862-1 
  7. Public Health England. COVID-19: review of disparities in risks and outcomes; 2020 Jun 2 [cited 2023 Jun 21]. Available from: https://www.gov.uk/government/publications/covid-19-review-of-disparities-in-risks-and-outcomes 
  8. Gollwitzer A, Martel C, Brady WJ, Parnamets P, Freedman IG, Knowles ED, et al. Partisan differences in physical distancing are linked to health outcomes during the COVID-19 pandemic. Nat Hum Behav 2020;4(11):1186-1197. https://doi.org/10.1038/s41562-020-00977-7 
  9. CoronaBoard. COVID-19 dashboard [cited 2023 Jun 21]. Available from: https://coronaboard.kr/ 
  10. Diesel J, Sterrett N, Dasgupta S, Kriss JL, Barry V, Vanden Esschert K, et al. COVID-19 vaccination coverage among adults-United States, December 14, 2020-May 22, 2021. MMWR Morb Mortal Wkly Rep 2021;70(25):922-927. https://doi.org/10.15585/mmwr.mm7025e1 
  11. Khubchandani J, Sharma S, Price JH, Wiblishauser MJ, Sharma M, Webb FJ. COVID-19 vaccination hesitancy in the United States: a rapid national assessment. J Community Health 2021;46(2):270-277. https://doi.org/10.1007/s10900-020-00958-x 
  12. Cheng Z, Li Y. Racial and ethnic and income disparities in COVID-19 vaccination among Medicare beneficiaries. J Am Geriatr Soc 2022;70(9):2638-2645. https://doi.org/10.1111/jgs.17920 
  13. Zapata JP, Zamantakis A, Queiroz AA. Identification of determinants and implementation strategies to increase long-acting injectable PrEP for HIV prevention among Latino men who have sex with men (MSM). J Racial Ethn Health Disparities 2023. https://doi.org/10.1007/s40615-023-01678-3 
  14. Martino RJ, Krause KD, Griffin M, LoSchiavo C, Comer-Carruthers C, Karr AG, et al. A nationwide survey of COVID-19 testing in LGBTQ+populations in the United States. Public Health Rep 2021;136(4):493-507. https://doi.org/10.1177/00333549211018190 
  15. Brennan J, Kuhns LM, Johnson AK, Belzer M, Wilson EC, Garofalo R, et al. Syndemic theory and HIV-related risk among young transgender women: the role of multiple, co-occurring health problems and social marginalization. Am J Public Health 2012;102(9):1751-1757. https://doi.org/10.2105/AJPH.2011.300433 
  16. Shrestha R, Meyer JP, Shenoi S, Khati A, Altice FL, Mistler C, et al. COVID-19 vaccine hesitancy and associated factors among people with HIV in the United States: findings from a national survey. Vaccines (Basel) 2022;10(3):424. https://doi.org/10.3390/vaccines10030424 
  17. Cho BH. Sexuality, risk, & HIV/AIDS. Seoul: Nanam; 2008, p. 261-321 (Korean). 
  18. Kwon RH, Jung M. Associations between conventional healthy behaviors and social distancing during the COVID-19 pandemic: evidence from the 2020 Community Health Survey in Korea. J Prev Med Public Health 2022;55(6):568-577. https://doi.org/10.3961/jpmph.22.351 
  19. Centers for Disease Control and Prevention. Nonpharmaceutical interventions (NPIs) [cited 2023 Jun 27]. Available from: https://www.cdc.gov/nonpharmaceutical-interventions/ 
  20. Family Health International (FHI). Behavioral surveillance surveys: guidelines for repeated behavioral surveys in populations at risk of HIV. Arlington: FHI; 2000, p. 93-101. 
  21. Khanijahani A, Iezadi S, Gholipour K, Azami-Aghdash S, Naghibi D. A systematic review of racial/ethnic and socioeconomic disparities in COVID-19. Int J Equity Health 2021;20(1):248. https://doi.org/10.1186/s12939-021-01582-4 
  22. Etienne CF. COVID-19 has revealed a pandemic of inequality. Nat Med 2022;28(1):17. https://doi.org/10.1038/s41591-021-01596-z 
  23. Johnson-Agbakwu CE, Ali NS, Oxford CM, Wingo S, Manin E, Coonrod DV. Racism, COVID-19, and health inequity in the USA: a call to action. J Racial Ethn Health Disparities 2022;9(1):52-58. https://doi.org/10.1007/s40615-020-00928-y 
  24. Apolonio JS, da Silva Junior RT, Cuzzuol BR, Araujo GR, Marques HS, Barcelos IS, et al. Syndemic aspects between COVID-19 pandemic and social inequalities. World J Methodol 2022;12(5):350-364. https://doi.org/10.5662/wjm.v12.i5.350 
  25. Van Dyke ME, Mendoza MC, Li W, Parker EM, Belay B, Davis EM, et al. Racial and ethnic disparities in COVID-19 incidence by age, sex, and period among persons aged <25 years - 16 U.S. jurisdictions, January 1-December 31, 2020. MMWR Morb Mortal Wkly Rep 2021;70(11):382-388. https://doi.org/10.15585/mmwr.mm7011e1 
  26. Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 2020;383(27):2603-2615. https://doi.org/10.1056/NEJMoa2034577 
  27. Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 2021;384(5):403-416. https://doi.org/10.1056/NEJMoa2035389 
  28. Voysey M, Clemens SA, Madhi SA, Weckx LY, Folegatti PM, Aley PK, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 2021;397(10269):99-111. https://doi.org/10.1016/S0140-6736(20)32661-1 
  29. Thompson MG, Burgess JL, Naleway AL, Tyner HL, Yoon SK, Meece J, et al. Interim estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines in preventing SARS-CoV-2 infection among health care personnel, first responders, and other essential and frontline workers - eight U.S. locations, December 2020-March 2021. MMWR Morb Mortal Wkly Rep 2021;70(13):495-500. https://doi.org/10.15585/mmwr.mm7013e3 
  30. Deeks SG, Overbaugh J, Phillips A, Buchbinder S. HIV infection. Nat Rev Dis Primers 2015;1:15035. https://doi.org/10.1038/nrdp.2015.35 
  31. Blanco JL, Ambrosioni J, Garcia F, Martinez E, Soriano A, Mallolas J, et al. COVID-19 in patients with HIV: clinical case series. Lancet HIV 2020;7(5):e314-e316. https://doi.org/10.1016/S2352-3018(20)30111-9 
  32. Western Cape Department of Health in collaboration with the National Institute for Communicable Diseases, South Africa. Risk factors for coronavirus disease 2019 (COVID-19) death in a population cohort study from the Western Cape Province, South Africa. Clin Infect Dis 2021;73(7):e2005-e2015. https://doi.org/10.1093/cid/ciaa1198 
  33. Richman DD. Normal physiology and HIV pathophysiology of human T-cell dynamics. J Clin Invest 2000;105(5):565-566. https://doi.org/10.1172/JCI9478 
  34. Bernheim D, Buchmann N, Freitas-Groff Z, Otero S. The effects of large group meetings on the spread of COVID-19: the case of Trump rallies; 2020 [cited 2023 Jul 20]. Available from: https://siepr.stanford.edu/publications/working-paper/effects-large-group-meetings-spread-covid-19-case-trump-rallies 
  35. Imperial College COVID-19 Response Team. The global impact of COVID-19 and strategies for mitigation and suppression; 2020 [cited 2023 Jul 20]. Available from: https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-Global-Impact-26-03-2020.pdf